MAGEA1 and liver cancer: Indeed, MAGE-A1 is overexpressed in a significant percentage (≥ 20%, on average) of different tumor types, including colon [41], melanoma [42], and lung [43], as well as in a low percentage (~ 10%) of breast [44] and liver cancers [45].